Loading organizations...
Loading organizations...
Emerging pharmaceutical company developing novel small molecule drugs.
Vantia Therapeutics has raised $6.4M across 1 funding round.
Vantia Therapeutics has raised $6.4M in total across 1 funding round.
Vantia Therapeutics has raised $6.4M in total across 1 funding round.
Vantia Therapeutics's investors include Novo Holdings, SV Health Investors, MVM Partners.
Vantia Therapeutics has raised $6.4M across 1 funding round. Most recently, it raised $6.4M Series B in July 2011.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 8, 2011 | $6.4M Series B | Novo Holdings, SV Health Investors | MVM Partners |